Medochemie and TDI APJ Kick Off SAP S/4HANA Project to Enhance Pharmaceutical Operations
Ho Chi Minh City, Vietnam – September 18, 2025 – Medochemie has officially kicked off their SAP S/4HANA Cloud implementation project, marking a significant milestone in the company’s digital transformation strategy. This initiative aims to optimize business processes, improve management efficiency, and ensure compliance with the stringent regulatory standards of the pharmaceutical industry.
The ceremony was attended by
Mr. Gregory Charitonos, CEO of Medochemie;
Mr. Kazuo Hosoi, COO TDI APJ
Mr. David Tan, Managing Director of TDI APJ Vietnam;
Mr. Alex Chen, Vice President-Consulting of TDI APJ
Digital Transformation in the Pharmaceutical Industry with SAP S/4HANA
The pharmaceutical industry has made significant advancements in research and development, yet it continues to face persistent challenges:
• A fragmented distribution network complicating supply chain management.
• Rising operational costs due to manual processes in production and administration
• Stringent compliance requirements from global regulatory bodies such as the FDA and EMA
SAP S/4HANA provides a comprehensive solution that enables pharmaceutical companies to enhance operational efficiency, boost productivity, and make data-driven decisions in real time, while upholding the highest standards of data integrity across all business functions. In a highly regulated industry like pharmaceuticals, data integrity is not just a technical requirement, it is a cornerstone of regulatory compliance, patient safety, and product quality. Ensuring that data is accurate, consistent, complete, and secure is essential for meeting international standards such as GMP, FDA, and ISO.
Key advantages include:
• Real-time inventory tracking with validated and synchronized data to prevent discrepancies and ensure accurate stock levels.
• End-to-end quality control from production to distribution, supported by secure, auditable, and tamper-proof data flows.
• Minimization of stock shortages and optimization of operational costs through trustworthy, up-to-date information.
• Accurate and traceable transactional and master data enabled by a robust data governance framework, reducing the risk of errors and duplication.
• Confident decision-making through full-scale digitalization, backed by reliable data that meets compliance and audit requirements.
• Centralized data management and automated validation rules that ensure consistency across departments and systems.
• Enhanced regulatory readiness through structured documentation, electronic records, and secure access controls.
Key Insights from the Event:
Mr. Gregory Charitonos – General Director of Medochemie – delivered a speech at the RISE with SAP project kick-off ceremony for the pharmaceutical industry.
Mr. Gregory Charitonos, CEO of Medochemie, stated:
“The implementation of SAP S/4HANA is a crucial step in Medochemie’s digital transformation journey. This solution will help us enhance our management capabilities, optimize operational processes, and ensure strict compliance with international pharmaceutical standards. The positive energy and collaborative spirit demonstrated during the kick-off have set a strong foundation for the journey ahead. SAP’s global best practices, combined with the hands-on guidance of TDI APJ and the deep business knowledge of our internal teams, give us confidence that we are building a solution that will truly support our future growth.”
Mr. Phu Bui – Project Manager shared: “This project stands as a strong example of commitment, cooperation, and collaboration. From the top-down commitment of our CEO to every manager and team member at Medochemie, to the close cooperation among internal departments, and the open collaboration with our external partners—everyone is aligned with the shared goal of delivering a successful SAP implementation. Together, we are determined to do things right and ensure the project is well executed as planned.”
Mr. Kazuo Hosoi – Chief Operating Officer (COO) of TDI APJ – shared at the project kick-off ceremony, emphasizing that the pharmaceutical industry is also one of TDI APJ’s key focus sectors.
Mr. Kazuo Hosoi, COO from TDI APJ, shared:
“We are honored to collaborate with Medochemie on this project. With our extensive experience in SAP S/4HANA implementation for major enterprises, TDI APJ is committed to delivering an optimal solution that enables Medochemie to maximize the potential of SAP S/4HANA and drive sustainable growth. This marks the beginning of our long-term partnership journey, and we look forward to achieving great milestones together.”
Leaders and members from Medochemie, TDI APJ, and SAP attended the ceremony to hear about the strategic direction, pharmaceutical industry best practices, and the reasons why the SAP S/4HANA project is a timely initiative that requires the involvement of all departments.
Mr. Alex Chen, Vice President-Consulting of TDI APJ, emphasized:
“The pharmaceutical industry demands high precision and strict regulatory compliance. With SAP S/4HANA, Medochemie will have a robust technological foundation to streamline production processes, improve operational efficiency, and manage quality according to global standards.”
Mr. Kazuo Hosoi – Chief Operating Officer (COO) of TDI APJ – and Mr. Gregory Charitonos – General Director of Medochemie – at the project kick-off ceremony.
Representatives from Medochemie, TDI APJ, and SAP, together with the project teams of both parties, took a commemorative photo at the RISE with SAP kick-off ceremony for the pharmaceutical industry.
Strategic Partnership Between Medochemie and TDI APJ
The SAP S/4HANA implementation project marks a key milestone in Medochemie’s growth strategy, strengthening its competitive edge in the pharmaceutical industry. With TDI APJ as a strategic SAP implementation partner, Medochemie aims to complete the project on schedule, ensuring smooth system deployment and long-term business value.
About Medochemie
Medochemie is an international company that develops, manufactures, and distributes licensed branded generic pharmaceutical products. Established in Cyprus (Europe) in 1976, it has today 19 offices and exports its products in more than 122 countries around the globe. Medochemie has fifteen manufacturing plants and facilities designed to fully comply with European and WHO Good Manufacturing Practices (GMP): nine are in Cyprus, one in the Netherlands, and five in Vietnam. Medochemie globally maintains 5,145 marketing authorization licenses for 630 different pharmaceutical products, classified into over 10 therapeutic categories.
About TDI APJ
TDI APJ is a premier SAP implementation partner, specializing in ERP solutions that streamline operations, enhance productivity, and support long-term business growth. With deep expertise in SAP S/4HANA deployments across industries, TDI APJ empowers organizations to unlock the full potential of digital transformation.